Objective: Children born small for gestational age (SGA) are at risk of future obesity and
associated comorbidities. Therefore the identification of risk factors and novel biomarkers …

Spexin is a newly described peptide and is known to reduce the uptake of long-chain fatty
acids into adipocytes. The serum spexin levels of obese children between the ages of 12–18 …

Background and aims Spexin (SPX) is a novel peptide recently discovered as an important
regulatory adipokine in obesity and related metabolic diseases. The aim of the current study …

Context: Spexin is a novel peptide that is implicated in obesity and related energy
homeostasis in animals and adult humans. Little is known about its role in children …

Objective: Spexin (SPX) is a novel peptide implicated in food intake and satiety. SPX levels
are reduced in obese patients. Aim: This study aimed to compare serum SPX levels in obese …

Objectives: Spexin (SPX) is a novel peptide that has recently emerged as an important
regulatory adipokine of obesity and related metabolic disease. Little is known about its role …

Spexin (SPX) is a peptide that plays an important role in the regulation of food intake and
body weight (BW) by the effect on carbohydrate-lipid metabolism. However, the role of SPX …

Children born small (SGA) or large (LGA) for gestational age are prone to develop insulin
resistance (IR) during childhood. Visfatin, a hormone with insulin-mimetic actions, has been …

The Spexin gene is considered the most dysregulated in obese human fat. Limited data
suggest that the novel peptide spexin may potentially impact food intake, weight regulation …

Objective Visfatin is an adipocytokine involved in insulin action and oxidative stress. The
regulation of circulating concentrations in the human foetus is unknown. We studied …